Cracking the Medical Scandal

Introduction to "Cracking the Medical Industry’s Game"

In 2026, the AI healthcare sector is engulfed in fierce competition. Shen Zhiyan, founder of Ruiying Medical, breaks through with low-dose AI imaging technology, only to face a relentless assault from industry giant Kangying Tech: a barrage of patent lawsuits, roadblocks in insurance pre-approval, the poaching of key talent, and even an infiltrator sabotaging the data. At this critical juncture, CFO Su Wan builds a financial bulwark through cross-border financing and counters the smear campaign with precise data.

The two join forces, one leading the push for technological breakthroughs and the other navigating the battle for capital. Facing the ethical dilemma of using Kangying’s misdiagnosis data to strike back, even if that exposes their allies, they seek breakthroughs in community hospitals and a lifeline in overseas markets. Ultimately, they reshape the industry by forging a technology alliance and establish ethical standards for medical AI. This is more than a business showdown: it is a story of wisdom and conscience standing firm amid the whirlpool of capital.